Insights Into Heart-Tumor Interactions in Heart Failure
Circulation Research · 23.05.2025 · 136 (11) · 1262-1285
DOI: 10.1161/circresaha.124.325490 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Circulation Research, erschienen am 23.05.2025. Verfasst von Tal Caller und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neufeld and Tamman Cardiovascular Research Institutes, Faculty of Medical and Health Sciences, Tel Aviv University, Israel (T.C., J.L.). Hauptthemen laut MEDLINE: Heart Failure, Neoplasms. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 262 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIGMS NIH HHS.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Heart failure (HF) often coexists with cancer. Beyond the known cardiotoxicity of some cancer treatments, HF itself has been associated with increased cancer incidence. The 2 conditions share common risk factors, mechanisms, and interactions that can worsen patient outcomes. The bidirectional relationship between HF and cancer presents a complex interplay of factors that are not fully understood. Recent preclinical evidence suggests that HF may promote tumor growth via the release of protumorigenic factors from the injured heart, revealing HF as a potentially protumorigenic condition. Our review discusses the biological crosstalk between HF and cancer, emphasizing the impact of HF on tumor growth, with inflammation, and modulating the immune system as central mechanisms. We further explore the clinical implications of this connection and propose future research directions. Understanding the mechanistic overlap and interactions between HF and cancer could lead to new biomarkers and therapies, addressing the growing prevalence of both conditions and enhancing approaches to diagnosis, prevention, and treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Neufeld and Tamman Cardiovascular Research Institutes, Faculty of Medical and Health Sciences, Tel Aviv University, Israel (T.C., J.L.).
- Lev Leviev Cardiovascular and Thoracic Center, Sheba Medical Center, Tel Hashomer, Israel (T.C., J.L.).
- Department of Medicine, Cardiovascular Research Center, New York University Grossman School of Medicine (K.J.M.).
- Department of Cardiology, University Hospital Heidelberg, Germany (L.H.L.).
- German Center of Cardiovascular Research (DZHK), Partnersite Heidelberg/Mannheim, Germany (L.H.L.).
- German Cancer Research Center (DKFZ), Heidelberg, Germany (L.H.L.).
ORCID-Profile: Tal Caller, Kathryn J Moore, Lorenz H Lehmann, Sean M Wu, Jonathan Leor
Förderung
- NHLBI NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Caller, T., Moore, K. J., Lehmann, L. H., Wu, S. M., & Leor, J. (2025). Insights Into Heart-Tumor Interactions in Heart Failure. Circulation Research, 136(11), 1262-1285. https://doi.org/10.1161/circresaha.124.325490
Vancouver
Caller T, Moore KJ, Lehmann LH, Wu SM, Leor J. Insights Into Heart-Tumor Interactions in Heart Failure. Circulation Research. 2025;136(11):1262-1285. doi:10.1161/circresaha.124.325490
BibTeX
@article{Caller2025,
author = {Caller, Tal and Moore, Kathryn J and Lehmann, Lorenz H and Wu, Sean M and Leor, Jonathan},
title = {Insights Into Heart-Tumor Interactions in Heart Failure},
journal = {Circulation Research},
year = {2025},
volume = {136},
number = {11},
pages = {1262--1285},
doi = {10.1161/circresaha.124.325490}
}
EUVIMED